Table of Contents

Volume 8, Issue 2

  February 2012

View covers archive

EDITOR'S CORNER

Open Access Article

Letter from the Editor

Ronald W. Ellis and Eva M. Riedmann


Open Access Article

Human Vaccines & Immunotherapeutics awards Top Reviewer of the Year

Eva M. Riedmann





NEWS, POLICY AND PROFILES

Open Access Article

News

Eva M. Riedmann





BOOK REVIEW

Deadly Choices : How the Anti-Vaccine Movement Threatens Us All

Ian Gust





PRODUCT HISTORY

Bexsero: A multicomponent vaccine for prevention of meningococcal disease

Andrew R. Gorringe and Rolando Pajón





SHORT REPORT

Evaluation of the establishment of herd immunity in the population by means of serological surveys and vaccination coverage

Pedro Plans-Rubió





RESEARCH PAPERS

Preparation and evaluation of immunogenic conjugates of Salmonella enterica serovar Typhi O-specific polysaccharides with diphtheria toxoid


Aamir Ali, So Jung An, Changfa Cui, Abdul Haque and Rodney Carbis


Comparison of antigen expression from plasmid DNA in tumor-free and antigen-expressing tumor-bearing mice

Xin Guan, Makiya Nishikawa, Hisoon Li, Yuki Takahashi and Yoshinobu Takakura


The burden of hospitalizations for anus and penis neoplasm in Spain (1997–2008)

Ruth Gil-Prieto, Pablo Viguera Ester, Alejandro Álvaro-Meca, María San Martín Rodríguez and Angel Gil de Miguel


Immunogenicity of a multi-epitope DNA vaccine against hantavirus

Chen Zhao, Ying Sun, Yujie Zhao, Si Wang, Tongtong Yu, Feng Du, X. Frank Yang and Enjie Luo


Superior immunogenicity of seasonal influenza vaccines containing standard dose of MF59^® adjuvant: Results from a dose-finding clinical trial in older adults

Giovanni Della Cioppa, Uwe Nicolay, Kelly Lindert, Geert Leroux-Roels, Frederic Clement, Flora Castellino, Grazia Galli, Nicola Groth and Giuseppe Del Giudice


Are age-based strategies effective in increasing influenza vaccination coverage? The Spanish experience

Rodrigo Jiménez-García , Valentín Hernández-Barrera, Cristina Rodríguez-Rieiro, Ana Lopez de Andres, Javier de Migue-Diez, Isabel Jimenez Trujillo and Pilar Carrasco-Garrido


National patterns in human papillomavirus vaccination: An analysis of the National survey of family growth

Gelareh Sadigh, Amanda F. Dempsey, Mack Ruffin, Ken Resnicow and Ruth C. Carlos


The cost efficiency of HPV vaccines is significantly underestimated due to omission of conisation-associated prematurity with neonatal mortality and morbidity

Philipp Soergel, Lars Makowski, Cordula Schippert, Ismini Staboulidou, Ursula Hille and Peter Hillemanns


Improvement of influenza vaccine strain A/Vietnam/1194/2004 (H5N1) growth with the neuraminidase packaging sequence from A/Puerto Rico/8/34

Weiqi Pan, Zhenyuan Dong, Weixu Meng, Wei Zheng, Ting Li, Chufang Li, Beiwu Zhang and Ling Chen


Characterization and long-term persistence of immune response following two doses of an AS03A-adjuvanted H1N1 influenza vaccine in healthy Japanese adults

Hideyuki Ikematsu, Hideaki Nagai, Masahiro Kawashima, Yasunobu Kawakami, Kazuyoshi Tenjinbaru, Ping Li, Karl Walravens, Paul Gillard and François Roman





COMMENTARIES

Current cell-based Influenza vaccine production technology as pandemic contingency

Say Kong Ng


Rotavirus vaccine can save millions of children’s lives in developing countries

Ramesh Verma, Pardeep Khanna and Suraj Chawla


Perceptions of pandemic influenza vaccines

Cecile A. Marczinski





LETTER

Use of intranasal live attenuated influenza vaccine in individuals with asthma or a history of wheezing

Christopher S. Ambrose